The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging life sciences products for both pandemic and non-pandemic scenarios.
LSIMF will provide up to £520m in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products).
You are required to submit an Expression of Interest (EOI) with a summary of your project which will be used to assess your project’s eligibility and can be submitted at any time whilst the fund is open to applications. If your project is deemed eligible, you will be invited to submit an application.
You may submit an EOI at any time, but are advise that you submit it at least one week prior to the application deadlines listed below if you wish for it to be considered in the next application round.
Applications will undergo assessment in quarterly rounds until all the funding has been allocated:
- Round 1 will open for applications on 30 October 2024 and close on 29 November 2024 at 12 PM
- Round 2 will open on 01 February 2024 and close on 28 February 2025 at 12 PM
- Round 3 will open on 01 May 2025 and close on 30 May 2025 at 12 PM
- Round 4 will open on 01 August 2025 and close on 29 August 2025 at 12 PM.
Subsequent application rounds will open on a quarterly basis until all the funding has been allocated.
For more information and to apply, click here.